David Fractor, VP of Finance at ImmunoCellular Therapeutics, Ltd. (IMUC), bought 16,667 shares at $0.60 ($10K) on 2015-02-18, disclosed to the SEC on 2015-02-20.
Open-market purchase of $10k IMUC by VP of Finance. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.